selected publications
-
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.
Arthritis research & therapy.
2024
Academic Article
GET IT
Times cited: 7 -
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
Journal of the American Academy of Dermatology.
2024
Guideline
GET IT
Times cited: 3 -
Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation.
Journal of the American Academy of Dermatology.
2023
Academic Article
GET IT
Times cited: 4 -
National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine.
JAAD international.
2023
Academic Article
GET IT
Times cited: 3 - Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study. BMC rheumatology. 2023 Academic Article GET IT
-
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations.
The Journal of rheumatology.
2022
Review
GET IT
Times cited: 15 -
Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review.
Medicine.
2022
Review
GET IT
Times cited: 5 -
Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials.
Rheumatology and therapy.
2022
Academic Article
GET IT
Times cited: 11 -
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Arthritis research & therapy.
2022
Academic Article
GET IT
Times cited: 15 - Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset. ACR open rheumatology. 2022 Academic Article GET IT
-
Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs.
RMD open.
2022
Review
GET IT
Times cited: 28 -
A Road Map of the Axial Spondyloarthritis Continuum.
Mayo Clinic proceedings.
2021
Review
GET IT
Times cited: 18 -
Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials.
2021
GET IT
Times cited: 1 -
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study.
Rheumatology and therapy.
2021
Academic Article
GET IT
Times cited: 7 - MRI Assessment of Sacroiliitis With High-Resolution Protocol. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2021 Academic Article GET IT
- Utility of magnetic resonance imaging in Crohn's associated sacroiliitis: A cross-sectional study. International journal of rheumatic diseases. 2021 Academic Article GET IT
-
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.
Journal of the American Academy of Dermatology.
2021
Guideline
GET IT
Times cited: 88 -
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials.
Rheumatology (Oxford, England).
2020
Review
GET IT
Times cited: 56 -
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
Journal of the American Academy of Dermatology.
2020
Guideline
GET IT
Times cited: 45 -
Association of High Serum Interleukin-6 Levels With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or Methotrexate in a Post Hoc Analysis.
Arthritis & rheumatology (Hoboken, N.J.).
2020
Academic Article
GET IT
Times cited: 38 - Controversies in Rheumatology. Rheumatic diseases clinics of North America. 2019 Editorial Article GET IT
-
Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?.
Rheumatic diseases clinics of North America.
2019
Review
GET IT
Times cited: 10 -
ALIGN PsA: Advancing a Multidisciplinary Approach in PsA.
Seminars in cutaneous medicine and surgery.
2018
Review
GET IT
Times cited: 10 -
Enthesitis and Dactylitis in Psoriatic Disease: A Guide for Dermatologists.
American journal of clinical dermatology.
2018
Review
GET IT
Times cited: 43 -
Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review.
JAMA dermatology.
2018
Academic Article
GET IT
Times cited: 139 -
Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy.
Advances in therapy.
2017
Academic Article
GET IT
Times cited: 50 -
Economic impact of biologic utilization patterns in patients with psoriatic arthritis.
Clinical rheumatology.
2017
Academic Article
GET IT
Times cited: 14 -
IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation.
Science translational medicine.
2017
Academic Article
GET IT
Times cited: 244 -
Advancements in the management of uveitis.
Best practice & research. Clinical rheumatology.
2016
Review
GET IT
Times cited: 35 -
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group.
Clinical rheumatology.
2016
Academic Article
GET IT
Times cited: 22 -
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Arthritis & rheumatology (Hoboken, N.J.).
2016
Guideline
GET IT
Times cited: 790 -
The Use of Biologic Therapies in Uveitis.
Clinical reviews in allergy & immunology.
2015
Information Resource
GET IT
Times cited: 18 -
Recognizing and managing comorbidities in psoriatic arthritis.
Current opinion in rheumatology.
2015
Review
GET IT
Times cited: 154 -
Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.
The Journal of rheumatology.
2014
Review
GET IT
Times cited: 63 -
Whipple's disease.
Rheumatic diseases clinics of North America.
2013
Information Resource
GET IT
Times cited: 10 -
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.
Dermatology and therapy.
2012
Academic Article
GET IT
Times cited: 40 -
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1.
Dermatology and therapy.
2012
Academic Article
GET IT
Times cited: 2 -
Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
Arthritis and rheumatism.
2011
Academic Article
GET IT
Times cited: 59 -
Patient perceptions concerning pain management in the treatment of rheumatoid arthritis.
The Journal of international medical research.
2010
Academic Article
GET IT
Times cited: 134 -
A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach.
Journal of the American Academy of Dermatology.
2009
Academic Article
GET IT
Times cited: 27 -
Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.
Annals of the rheumatic diseases.
2006
Academic Article
GET IT
Times cited: 139 -
Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?.
Arthritis research & therapy.
2004
Review
GET IT
Times cited: 34 -
Does route of administration affect the outcome of TNF antagonist therapy?.
Arthritis research & therapy.
2004
Review
GET IT
Times cited: 74 -
Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome.
Arthritis and rheumatism.
2000
Academic Article
GET IT
Times cited: 107 -
Validation of the Sapporo criteria for antiphospholipid syndrome.
Arthritis and rheumatism.
2000
Academic Article
GET IT
Times cited: 183 -
Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment.
Seminars in arthritis and rheumatism.
1997
Review
GET IT
Times cited: 164 -
Carbohydrates on human Fc gamma receptors. Interdependence of the classical IgG and nonclassical lectin-binding sites on human Fc gamma RIII expressed on neutrophils.
Journal of immunology (Baltimore, Md. : 1950).
1989
Academic Article
GET IT
Times cited: 44 -
Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
Clinical and experimental immunology.
1988
Academic Article
GET IT
Times cited: 13 -
Idiopathic hypertrophic osteoarthropathy without pachyderma and with acrolysis.
1982
GET IT
Times cited: 3